Nuclear receptors (NRs) are ligand-dependent transcription factors which regulate the expression of responsive genes and thereby affect diverse processes, including cell growth, development, differentiation and metabolism.
Based on the elucidated human genome sequence, 48 NRs are thought to exist in humans. 1) NRs are divided into four subfamilies, including (1) classical steroid hormone receptors, (2) 1) The LXRs are members of the metabolic receptor subfamily of the NR superfamily, and consist of two subtypes, LXRa and LXRb. The physiological ligands of LXRs are considered to be oxysterols, such as 24(S),25-epoxycholesterol (1, EPC), [1] [2] [3] and several synthetic agonists, including GW3965 (2) and T0901317 (3), have been reported (Fig. 1) . 4, 5) LXRs function as heterodimers with other nuclear receptors, the retinoid X receptors (RXRa, RXRb and RXRg), to regulate important aspects of cholesterol homeostasis by controlling expression of their target genes, including ATP binding cassette ABCA1 and CYP7A genes. 6, 7) LXRs also regulate the expression of several genes involved in glucose metabolism. 8, 9) We have been engaged in structural development studies of thalidomide, a drug first launched as a sedative/hypnotic agent, but withdrawn from the market because of its severe teratogenicity, focusing on its potential for the treatment of a range of diseases, including cancers, diabetes, and rheumatoid arthritis. [11] [12] [13] [14] [15] We have developed a series of potent aglucosidase inhibitors, including CP0P (4), CP4P (5) and PPS-33 (6) (Fig. 2) . [11] [12] [13] [14] [15] [16] [17] [18] CP0P (4) is a non-competitive inhibitor of a-glucosidase, whereas CP4P (5) is a competitive inhibitor. [16] [17] [18] PPS-33 (6) is another competitive a-glucosidase inhibitor, but it also inhibits other enzymes, including maltase and dipeptidylpeptidase type IV. 19) The competitive inhibition of a-glucosidase by CP4P (5) and PPS-33 (6) indicated that these compounds might be structural mimics of glucose. On this basis, we found that CP4P (5) and PPS-33 (6) act as antagonists for LXRs. 20) Our former structural development studies based on CP4P (5) suggested that 2Ј-hydrophobic substituents enhance the LXR antagonistic activity of the compounds, and PP2P (7) and PP-60 (8) have been reported to be moderate LXR antagonists. 20) In this paper, we describe the structure-activity relationship of the 2Ј-alkyl group and further structural development of LXR antagonists based on the N-2Ј-alkylphenylphthalimide skeleton.
Structural Development of Liver X Receptor (LXR) Antagonists Derived from Thalidomide-Related Glucosidase Inhibitors
Tomomi NOGUCHI-YACHIDE, a Hiroyuki MIYACHI, a Hiroshi AOYAMA, a Atsushi AOYAMA, Effect of the 2-Alkyl Group As previously reported, PP-60 (8) shows moderate antagonistic activity toward LXRs, while the corresponding non-substituted phenylpthalimide (PP-00: 9) has only very weak activity. 20) To find the optimum alkyl chain length of the 2Ј-alkyl substituent, we prepared derivatives with different alkyl chain length, i.e., PP-10 (10), PP-20 (11), PP-30 (12), PP-40 (13), PP-50 (14) and PP-70 (15) ( Table 1 ). All of the compounds were prepared by condensation of an appropriate o-alkylaniline with phthalic anhydride. The LXR antagonistic activity of the prepared compounds was evaluated using a reporter gene assay method with CMX-GAL4N-hLXR as the recombinant receptor gene, TK-MH100x4-LUC as the reporter gene and the CMX b-galactosidase gene for normalization, as previously reported, [21] [22] [23] and the results are shown in Table 1 . None of the prepared compounds exhibited any LXR agonistic activity (data not shown).
As shown in Table 1 , the effect of 2Ј-alkyl chain length on the LXR antagonistic activity of the compounds was clear. The compounds with no alkyl group or an alkyl group shorter than an ethyl group, i.e., PP-00 (9) and PP-10 (10), showed only very weak antagonistic activity toward both LXRa and LXRb. The ethyl analog, PP-20 (11), showed also very weak antagonistic activity toward LXRb, but it had moderate antagonistic activity toward LXRa. The antagonistic activity of compounds with a 2Ј-alkyl chain longer than a methyl group increased in the order of: PP-20 (11)ϽPP-30 (12)ϽPP-40 (13)ϽPP-50 (14), for both LXRa and LXRb. Further elongation of the 2Ј-alkyl chain, i.e., PP-60 (8) and PP-70 (15), scarcely affected (in the case of LXRa), or seemed to slightly decrease (for LXRb) the activity. Thus, the 2Ј-n-pentyl group [PP-50 (14)] seemed to be the best substituent for LXR antagonistic activity. The substituent effect on antagonistic activity seemed to be greater for LXRa than for LXRb. The IC 50 values of PP-50 (14) were calculated to be 42-45 mM and 69-82 mM for LXRa and LXRb, respectively (Fig. 4, Table 2 ). (Fig. 3) , suggested that 5-chlorination and/or thiocarbonylation of the phthalimide moiety enhance the activity. 20 ) Therefore, we examined the effects of 5-chlorination and/or thiocarbonylation of PP-50 (14) , i.e., 5CPP-50 (20) , PPS-50 (21), PPSS-50 (22) , and 5CPPSS-50 (23) (Fig. 3) . All of the compounds were prepared by usual organic synthetic methods, and their LXR antagonistic activity was evaluated as described in Experimental. None of these compounds showed LXR agonistic activity.
Effects of 5-Chloro Substitution and Thiocarbonylation Our previous and preliminary results, i.e., (i) 5CP4P (16) possesses more potent antagonistic activity toward both LXRa and LXRb than 56CP4P (17) or CP4P (18), and (ii) PPS-33 (6) is a moderately potent LXR antagonist while PP-33 (19) is not
As expected, 5-chlorination enhanced the antagonistic activity toward both LXRa and LXRb (Fig. 4, Table 2 ): 5CPP-50 (20) is a more potent LXR antagonist than PP-50 (14) . Monothiocarbonylation of PP-50 (14) also resulted in enhancement of the activity, as expected: PPS-50 (21) is more active than PP-50 (14) ( Table 2 ). Further thiocarbonylation of PPS-50 (21), i.e., PPSS-50 (22), had little effect on LXRa antagonistic activity, but enhanced the LXRb antagonistic activity. Based on these results, 5-chloro-N-2Ј-n-pentylphenyl-1,3-dithiophthalimide (5CPPSS-50: 23) was designed and prepared, and was found to be the most potent LXR antagonist among the prepared compounds, with IC 50 values of 9.9-10 mM and 12-14 mM for LXRa and LXRb, respectively (Table 2) .
Conclusion
In conclusion, LXR antagonists based on N-2Ј-alkylphenylphthalimide were structurally developed. As the 2Ј-alkyl group, an n-pentyl group was determined to be the best substituent. Further structural development resulted in 5CPPSS-50 (23) , which has IC 50 values of around 10 mM for antagonistic activity towards both LXRs. Further structural development and biological studies of 5CPPSS-50 (23) are in progress. 
Experimental
General Melting points were determined by using a Yanagimoto hotstage melting point apparatus and are uncorrected.
1 H-NMR spectra were recorded on a JEOL JNM-GX500 (500 MHz) spectrometer. Chemical shifts are expressed in parts per million relative to tetramethylsilane. Mass spectra were recorded on a JEOL JMS-DX303 spectrometer. For silica gel chromatography, Silica Gel 60 (Cica-Reagent Co. Ltd.) was used. N-2-n-Propylphenylphthalimide (PP-30: 12) Ethyl triphenyl phosphonium bromide (1229 mg, 3.31 mmol) in THF (25 ml) was treated with 1 eq BuLi (1.6 M n-hexane solution, 2.04 ml) under ice cooling (stirred for 20 min). Then, 2-nitrobenzaldehylde (500 mg) in THF (1 ml) was added in aliquots, and stirred for 1 h. The resulted mixture was washed with water and separated by silica gel chromatography (AcOEt : n-hexaneϭ1 : 1.15 v/v) to give 271 mg pale yellow oil (crude yield: 50%). The oil was dissolved in 10 ml EtOH and hydrogenated in the presence of 10% Pd/C (20 mg) under an H 2 atmosphere for 2 h to give 2-n-propylaniline quantitatively. The obtained 2-n-propylaniline was mixed with phthalic anhydride (121 mg) and heated at 160°C to melt under an Ar atmosphere for 1 h. The resulted mixture was separated by silica gel chromatography (AcOEt : n-hexaneϭ1 : 5 v/v) to give PP-30 (376 mg, y: 92%). The total yield was 46%. mp 94-95°C. 1 
